Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Atovaquone‐proguanil for treating uncomplicated malaria

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD004529.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 19 octubre 2005see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Enfermedades infecciosas

Clasificada:
  1. Pendiente de actualización

    Authors currently updating

    The update is due to be published in 2019.

    Evaluada: 22 March 2019

Copyright:
  1. Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Alex Osei‐Akoto

    Correspondencia a: Department of Child Health, Komfo Anokye Teaching Hospital, Kumasi, Ghana

    [email protected]

  • Lois C Orton

    School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK

  • Shirley Owusu‐Ofori

    Department of Medicine, Komfo Anokye Teaching Hospital, Kumasi, Ghana

Contributions of authors

Alex Osei‐Akoto and Shirley Owusu‐Ofori drafted the review, and Lois Orton commented on the review. All three authors completed the review.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • Department for International Development, UK.

Declarations of interest

None known.

Acknowledgements

The protocol for this Cochrane Review was developed during the Mentorship Programme organized by the Cochrane Infectious Diseases Group, July 2002. The UK Department for International Development (DFID) supports this Programme through the Effective Health Care Alliance Programme (EHCAP) at the Liverpool School of Tropical Medicine. Alex Osei‐Akoto and Shirley Owusu‐Ofori received funding from DFID through EHCAP to travel to the Liverpool School of Tropical Medicine to complete the review. Harriet G MacLehose (Assistant Editor, Cochrane Infectious Disease Group) resolved disagreements between authors about trial selection and data extraction.

This document is an output from a project funded by DFID for the benefit of developing countries. The views expressed are not necessarily those of DFID.

Version history

Published

Title

Stage

Authors

Version

2021 Jan 18

Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria

Review

Andrew Blanshard, Paul Hine

https://doi.org/10.1002/14651858.CD004529.pub3

2005 Oct 19

Atovaquone‐proguanil for treating uncomplicated malaria

Review

Alex Osei‐Akoto, Lois C Orton, Shirley Owusu‐Ofori

https://doi.org/10.1002/14651858.CD004529.pub2

2003 Oct 20

Atovaquone‐proguanil for treating uncomplicated malaria

Protocol

A Osei‐Akoto, Lois C Orton, Shirley PO Owusu‐Ofori, Alex YA Osei

https://doi.org/10.1002/14651858.CD004529

Differences between protocol and review

Issue 4, 2005 (first review version): In line with the Cochrane Infectious Diseases Group (CIDG) new guidelines we no longer include quasi‐randomized controlled trials, modified the primary outcome measure (protocol: "Parasitaemia by days 14 and 28"), removed the secondary outcome measure "Parasitaemia by day 28, adjusted to exclude new infections using PCR", added "Treatment failure* on or by day 14" as a secondary outcome measure, and modified the method to assess blinding in trials.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.